Allergy/Imm
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



1. Report Shows Shift in Starting Salaries for Physicians
2. 2008 Exclusive Survey—Earnings: Good news for primary care income
3. Medicare pay-for-reporting effort draws fire from frustrated doctors
4. Debunking Myths in the US Healthcare System
5. Novel therapies for children with severe asthma

Top Ten Searches

hla
beta 2
probiotics
hypo allergenic
scid
urticaria
aeroallergens
asthma
angioedema
hiv

Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming
Immunology, 10/12/09

Li XL et al. – The data suggest that direct priming by TAP1 and B7.1 co–expressing tumour cells is potentially a major mechanism to facilitate immune responses against TAP–deficient tumour cells.

Related Articles

The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours
Clinical and Experimental Immunology, 10/06/09    Relevance Score: 66%

The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer
Acta Oncologica, 11/02/09    Relevance Score: 48%

Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial
European Journal of Cancer, 10/13/09    Relevance Score: 46%

Cutaneous metastasis from gastric glomus tumour
Clinical and Experimental Dermatology, 10/05/09    Relevance Score: 46%

Juxtarenal/pararenal Wilms’ tumour in a six-year-old Malay girl
Singapore Medical Journal, 10/05/09    Relevance Score: 46%

Today in Hematology/Oncology...keeping you current

Mutiny on the Boun-T: Controlling Dangerous T Cells Through Anergy
Discovery Medicine, 12/17/09

The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro
Journal of Immunology, 12/16/09

Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder
Cancer, 12/15/09

 See all of Hematology/Oncology

Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address